Advisory Cmte. Conflict-Of-Interest Waiver Details Should Be Public – Bristol

FDA advisory committee members granted conflict-of-interest waivers should be required to disclose the companies to which they have financial ties, Bristol-Myers Squibb said in comments to FDA